{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:28:31Z","timestamp":1792664911513,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T00:00:00Z","timestamp":1648252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T00:00:00Z","timestamp":1648252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"DOI":"10.1007\/s10103-022-03547-7","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T21:03:41Z","timestamp":1648501421000},"page":"2823-2830","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Comparison of fractional erbium:YAG laser-assisted tranexamic acid delivery alone and in combination with oral tranexamic acid in melasma"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9431-2125","authenticated-orcid":false,"given":"Aysenur","family":"Botsali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pelin","family":"Esme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Erbil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ercan","family":"Caliskan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,26]]},"reference":[{"issue":"4","key":"3547_CR1","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jaad.2011.06.001","volume":"65","author":"VM Sheth","year":"2011","unstructured":"Sheth VM, Pandya AG (2011) Melasma: a comprehensive update: part II. J Am Acad Dermatol 65(4):699\u2013714","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"3547_CR2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1684\/ejd.2010.0912","volume":"20","author":"D Li","year":"2010","unstructured":"Li D, Shi Y, Li M, Liu J, Feng X (2010) Tranexamic acid can treat ultraviolet radiation-induced pigmentation in guinea pigs. Eur J Dermatol 20(3):289\u2013292","journal-title":"Eur J Dermatol"},{"issue":"2\u20133","key":"3547_CR3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S1011-1344(98)00212-7","volume":"47","author":"K Maeda","year":"1998","unstructured":"Maeda K, Naganuma M (1998) Topical trans-4-aminomethylcyclohexanecarboxylic acid prevents ultraviolet radiation-induced pigmentation. J Photochem Photobiol B Biol 47(2\u20133):136\u2013141","journal-title":"J Photochem Photobiol B Biol"},{"issue":"4","key":"3547_CR4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1248\/jhs.53.389","volume":"53","author":"K Maeda","year":"2007","unstructured":"Maeda K, Tomita Y (2007) Mechanism of the inhibitory effect of tranexamic acid on melanogenesis in cultured human melanocytes in the presence of keratinocyte-conditioned medium. J Health Sci 53(4):389\u2013396","journal-title":"J Health Sci"},{"issue":"8","key":"3547_CR5","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/j.1468-3083.2012.04464.x","volume":"27","author":"JI Na","year":"2013","unstructured":"Na JI, Choi SY, Yang SH, Choi HR, Kang HY, Park KC (2013) Effect of tranexamic acid on melasma: a clinical trial with histological evaluation. J Eur Acad Dermatol Venereol 27(8):1035\u20131039","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"3547_CR6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jaad.2016.03.001","volume":"75","author":"HC Lee","year":"2016","unstructured":"Lee HC, Thng TGS, Goh CL (2016) Oral tranexamic acid (TA) in the treatment of melasma: a retrospective analysis. J Am Acad Dermatol 75(2):385\u2013392","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"3547_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3109\/00016349009036161","volume":"69","author":"Z Bekassy","year":"1990","unstructured":"Bekassy Z, \u00c5stedt B (1990) Treatment with the fibrinolytic inhibitor tranexamic acid\u2014risk for thrombosis? Acta Obstet Gynecol Scand 69(4):353\u2013354","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"3547_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4103\/0974-2077.118403","volume":"6","author":"L Budamakuntla","year":"2013","unstructured":"Budamakuntla L, Loganathan E, Suresh DH et al (2013) A randomised, open-label, comparative study of tranexamic acid microinjections and tranexamic acid with microneedling in patients with melasma. J Cutan Aesthet Surg 6(3):139","journal-title":"J Cutan Aesthet Surg"},{"key":"3547_CR9","doi-asserted-by":"publisher","unstructured":"Ghandehari R, Robati RM, Niknezhad N, Hajizadeh N, Tehranchinia Z (2020) Efficacy and safety of fractional CO2 laser and tranexamic acid versus microneedling and tranexamic acid in the treatment of infraorbital hyperpigmentation. J Dermatolog Treat.\u00a0https:\/\/doi.org\/10.1080\/09546634.2020.1819527","DOI":"10.1080\/09546634.2020.1819527"},{"issue":"11","key":"3547_CR10","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1097\/DSS.0000000000002520","volume":"46","author":"A Kaur","year":"2020","unstructured":"Kaur A, Bhalla M, Thami GP, Sandhu J (2020) Clinical efficacy of topical tranexamic acid with microneedling in melasma. Dermatol Surg 46(11):e96\u2013e101","journal-title":"Dermatol Surg"},{"key":"3547_CR11","doi-asserted-by":"crossref","unstructured":"Mekawy KMM, Sadek A, Seddeik Abdel\u2010Hameed AK (2020) Micro\u2010needling versus fractional carbon dioxide laser for delivery of tranexamic acid in the treatment of melasma: a split\u2010face study. J Cosmet Dermatol 20(2):460\u2013465","DOI":"10.1111\/jocd.13537"},{"issue":"1","key":"3547_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4103\/idoj.IDOJ_22_19","volume":"11","author":"A Menon","year":"2020","unstructured":"Menon A, Eram H, Kamath PR, Goel S, Babu AM (2020) A split face comparative study of safety and efficacy of microneedling with tranexamic acid versus microneedling with Vitamin C in the treatment of melasma. Indian Dermatol Online J 11(1):41","journal-title":"Indian Dermatol Online J"},{"key":"3547_CR13","doi-asserted-by":"crossref","unstructured":"Shamsi Meymandi S, Mozayyeni A, Shamsi Meymandi M, Aflatoonian M (2020) Efficacy of microneedling plus topical 4% tranexamic acid solution vs 4% hydroquinone in the treatment of melasma: A single\u2010blind randomized clinical trial. J Cosmet Dermatol 19(11):2906\u20132911","DOI":"10.1111\/jocd.13392"},{"issue":"12","key":"3547_CR14","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1111\/jocd.13810","volume":"19","author":"X Xing","year":"2020","unstructured":"Xing X, Chen L, Xu Z, Jin S, Zhang C, Xiang L (2020) The efficacy and safety of topical tranexamic acid (liposomal or lotion with microneedling) versus conventional hydroquinone in the treatment of melasma. J Cosmet Dermatol 19(12):3238\u20133244","journal-title":"J Cosmet Dermatol"},{"issue":"6","key":"3547_CR15","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1097\/DSS.0000000000001518","volume":"44","author":"HR Bala","year":"2018","unstructured":"Bala HR, Lee S, Wong C, Pandya AG, Rodrigues M (2018) Oral tranexamic acid for the treatment of melasma: a review. Dermatol Surg 44(6):814\u2013825","journal-title":"Dermatol Surg"},{"issue":"1","key":"3547_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jaad.2009.10.051","volume":"64","author":"AG Pandya","year":"2011","unstructured":"Pandya AG, Hynan LS, Bhore R et al (2011) Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method. J Am Acad Dermatol 64(1):78-83.e2","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"3547_CR17","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/jocd.12751","volume":"18","author":"H Abdel-Raouf Mohamed","year":"2019","unstructured":"Abdel-Raouf Mohamed H, Ali Nasif G, Saad Abdel-Azim E, Abd El-Fatah Ahmed M (2019) Comparative study of fractional erbium: YAG laser vs combined therapy with topical steroid as an adjuvant treatment in melasma. J Cosmet Dermatol 18(2):517\u2013523","journal-title":"J Cosmet Dermatol"},{"issue":"6","key":"3547_CR18","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jaad.2009.06.067","volume":"62","author":"PE Grimes","year":"2010","unstructured":"Grimes PE, Bhawan J, Guevara IL et al (2010) Continuous therapy followed by a maintenance therapy regimen with a triple combination cream for melasma. J Am Acad Dermatol 62(6):962\u2013967","journal-title":"J Am Acad Dermatol"},{"issue":"3pt1","key":"3547_CR19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/dsu.12060","volume":"39","author":"JU Shin","year":"2013","unstructured":"Shin JU, Park J, Oh SH, Lee JH (2013) Oral tranexamic acid enhances the efficacy of low-fluence 1064-nm quality-switched neodymium-doped yttrium aluminum garnet laser treatment for melasma in Koreans: a randomized, prospective trial. Dermatol Surg 39(3pt1):435\u2013442","journal-title":"Dermatol Surg"},{"issue":"4","key":"3547_CR20","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3109\/09546634.2011.643220","volume":"24","author":"HH Cho","year":"2013","unstructured":"Cho HH, Choi M, Cho S, Lee JH (2013) Role of oral tranexamic acid in melasma patients treated with IPL and low fluence QS Nd: YAG laser. J Dermatolog Treat 24(4):292\u2013296","journal-title":"J Dermatolog Treat"},{"issue":"5","key":"3547_CR21","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.jaad.2015.12.008","volume":"74","author":"M Haedersdal","year":"2016","unstructured":"Haedersdal M, Erlendsson AM, Paasch U, Anderson RR (2016) Translational medicine in the field of ablative fractional laser (AFXL)-assisted drug delivery: a critical review from basics to current clinical status. J Am Acad Dermatol 74(5):981\u20131004","journal-title":"J Am Acad Dermatol"},{"issue":"1\u20132","key":"3547_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0168-3659(01)00391-1","volume":"75","author":"WR Lee","year":"2001","unstructured":"Lee WR, Shen S-C, Lai H-H, Hu C-H, Fang J-Y (2001) Transdermal drug delivery enhanced and controlled by erbium: YAG laser: a comparative study of lipophilic and hydrophilic drugs. J Control Release 75(1\u20132):155\u2013166","journal-title":"J Control Release"},{"issue":"9","key":"3547_CR23","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/j.1600-0625.2010.01093.x","volume":"19","author":"B Forster","year":"2010","unstructured":"Forster B, Klein A, Szeimies RM, Maisch T (2010) Penetration enhancement of two topical 5-aminolaevulinic acid formulations for photodynamic therapy by erbium: YAG laser ablation of the stratum corneum: continuous versus fractional ablation. Exp Dermatol 19(9):806\u2013812","journal-title":"Exp Dermatol"},{"issue":"1","key":"3547_CR24","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1365-2133.2004.06051.x","volume":"151","author":"JY Fang","year":"2004","unstructured":"Fang JY, Lee WR, Shen SC, Fang YP, Hu CH (2004) Enhancement of topical 5-aminolaevulinic acid delivery by erbium: YAG laser and microdermabrasion: a comparison with iontophoresis and electroporation. Brit J Dermatol 151(1):132\u2013140","journal-title":"Brit J Dermatol"},{"issue":"4","key":"3547_CR25","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/jps.20577","volume":"95","author":"SC Shen","year":"2006","unstructured":"Shen SC, Lee WR, Fang YP, Hu CH, Fang JY (2006) In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium: YAG laser. J Pharm Sci 95(4):929\u2013938","journal-title":"J Pharm Sci"},{"issue":"5","key":"3547_CR26","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/1523-1747.ep12491600","volume":"97","author":"JS Nelson","year":"1991","unstructured":"Nelson JS, McCullough JL, Glenn TC, Wright WH, Liaw L-HL, Jacques SL (1991) Mid-infrared laser ablation of stratum corneum enhances in vitro percutaneous transport of drugs. J Invest Dermatol 97(5):874\u2013879","journal-title":"J Invest Dermatol"},{"issue":"2","key":"3547_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/ijd.12477","volume":"54","author":"E Attwa","year":"2015","unstructured":"Attwa E, Khater M, Assaf M, Haleem MA (2015) Melasma treatment using an erbium:YAG laser: a clinical, immunohistochemical, and ultrastructural study. Int J Dermatol 54(2):235\u2013244","journal-title":"Int J Dermatol"},{"key":"3547_CR28","doi-asserted-by":"crossref","unstructured":"Otb S, Shaarawy E, Sadek A et al (2021) A split face comparative study between intradermal tranexamic acid and Erbium-YAG laser in treatment of melasma. J Dermatolog Treat:1\u20135","DOI":"10.1080\/09546634.2020.1771259"},{"key":"3547_CR29","doi-asserted-by":"crossref","unstructured":"Kwon S-H, Hwang Y-J, Lee S-K, Park K-C (2016) Heterogeneous pathology of melasma and its clinical implications. Int J Mol Sci 17(6):824","DOI":"10.3390\/ijms17060824"},{"issue":"4","key":"3547_CR30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.12788\/j.sder.2016.060","volume":"35","author":"JY Li","year":"2016","unstructured":"Li JY, Geddes ER, Robinson DM, Friedman PM (2016) A review of melasma treatment focusing on laser and light devices. Semin Cutan Med Surg 35(4):223\u2013232","journal-title":"Semin Cutan Med Surg"},{"issue":"1","key":"3547_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/09546634.2019.1577544","volume":"31","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zheng X, Chen Z, Lu L (2020) Laser and laser compound therapy for melasma: a meta-analysis. J Dermatolog Treat 31(1):77\u201383","journal-title":"J Dermatolog Treat"},{"issue":"7","key":"3547_CR32","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1111\/jocd.13203","volume":"19","author":"E Berardesca","year":"2020","unstructured":"Berardesca E, Rigoni C, Cantu A et al (2020) Effectiveness of a new cosmetic treatment for melasma. J Cosmet Dermatol 19(7):1684\u20131690","journal-title":"J Cosmet Dermatol"},{"key":"3547_CR33","doi-asserted-by":"crossref","unstructured":"Caniglia RJ (2004) Erbium:YAG laser skin resurfacing. Facial Plast Surg Clin North Am 12(3):373\u20137, vii","DOI":"10.1016\/j.fsc.2004.03.005"},{"issue":"1","key":"3547_CR34","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jaad.2012.09.014","volume":"68","author":"M El-Domyati","year":"2013","unstructured":"El-Domyati M, Abd-El-Raheem T, Abdel-Wahab H et al (2013) Fractional versus ablative erbium:yttrium-aluminum-garnet laser resurfacing for facial rejuvenation: an objective evaluation. J Am Acad Dermatol 68(1):103\u2013112","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"3547_CR35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/jocd.12079","volume":"13","author":"M El-Domyati","year":"2014","unstructured":"El-Domyati M, Abd-El-Raheem T, Medhat W, Abdel-Wahab H, Al AM (2014) Multiple fractional erbium: yttrium-aluminum-garnet laser sessions for upper facial rejuvenation: clinical and histological implications and expectations. J Cosmet Dermatol 13(1):30\u201337","journal-title":"J Cosmet Dermatol"},{"key":"3547_CR36","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.biopha.2018.07.146","volume":"107","author":"K Hiramoto","year":"2018","unstructured":"Hiramoto K, Yamate Y, Sugiyama D, Matsuda K, Iizuka Y, Yamaguchi T (2018) Tranexamic acid inhibits the plasma and non-irradiated skin markers of photoaging induced by long-term UVA eye irradiation in female mice. Biomed Pharmacother 107:54\u201358","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"3547_CR37","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00403-019-01938-5","volume":"311","author":"K Hiramoto","year":"2019","unstructured":"Hiramoto K, Yamate Y, Sugiyama D, Matsuda K, Iizuka Y, Yamaguchi T (2019) Ameliorative effect of tranexamic acid on physiological skin aging and its sex difference in mice. Arch Dermatol Res 311(7):545\u2013553","journal-title":"Arch Dermatol Res"},{"issue":"5","key":"3547_CR38","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.clindermatol.2007.07.003","volume":"25","author":"K Riggs","year":"2007","unstructured":"Riggs K, Keller M, Humphreys TR (2007) Ablative laser resurfacing: high-energy pulsed carbon dioxide and erbium:yttrium-aluminum-garnet. Clin Dermatol 25(5):462\u2013473","journal-title":"Clin Dermatol"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-022-03547-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10103-022-03547-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-022-03547-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T08:00:27Z","timestamp":1744185627000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10103-022-03547-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,26]]},"references-count":38,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["3547"],"URL":"https:\/\/doi.org\/10.1007\/s10103-022-03547-7","relation":{},"ISSN":["1435-604X"],"issn-type":[{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,26]]},"assertion":[{"value":"23 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"G\u00fclhane Faculty of Medicine\u2019s ethical committee approved this study (2021\u201333). Only participants who signed the written informed consent were enrolled in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patients in this manuscript have given written informed consent to publication of their case details.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}